NASDAQ : PTCT
PTC Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 64.46 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 5.38B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
PTC Therapeutics, Inc. (PTCT) reported revenue of 1.16B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 1.16B | 1.73B | 806.78M | 937.82M | 698.80M | 538.59M |
| Cost of Revenue | 517.87M | 502.26M | 591.88M | 732.05M | 696.17M | 573.01M |
| Gross Profit | 637.69M | 1.23B | 214.90M | 205.77M | 2.63M | -34.42M |
| Selling, General & Admin | 343.77M | 347.14M | 300.91M | 332.54M | 326.00M | 285.77M |
| Amortization of Goodwill & Intangibles | 45.37M | 24.74M | 60.74M | 222.63M | 116.55M | 54.75M |
| Operating Expenses | 389.13M | 371.88M | 361.65M | 555.17M | 442.55M | 340.52M |
| Operating Income | 248.55M | 856.51M | -146.75M | -349.40M | -439.93M | -374.94M |
| Interest Expense | -198.42M | -152.23M | -170.39M | -129.18M | -90.87M | -86.02M |
| Currency Exchange Gain (Loss) | -5.10M | -23.10M | 1.10M | -31.30M | ||
| Other Non Operating Income (Expenses) | -10.44M | -4.68M | 97.02M | 11.81M | -615.00K | -45.19M |
| EBT Excluding Unusual Items | 34.59M | 676.50M | -219.02M | -466.78M | -562.71M | -506.15M |
| Gain (Loss) on Sale of Investments | 3.82M | 9.69M | 11.73M | -1.68M | -17.29M | -12.69M |
| Gain (Loss) on Sale of Assets | -100.00K | -4.40M | ||||
| Asset Writedown | -652.00K | -1.07M | -163.60M | -217.80M | -33.38M | |
| Other Unusual Items | -11.85M | 11.60M | 12.18M | -9.86M | 25.90M | 500.00K |
| Pretax Income | -85.09M | 696.62M | -363.12M | -696.11M | -587.49M | -518.34M |
| Income Tax Expense | 20.88M | 13.97M | 176.00K | -69.51M | -28.47M | 5.56M |
| Net Income | -105.97M | 682.64M | -363.30M | -626.60M | -559.02M | -523.90M |
| Net Income to Common | -105.97M | 682.64M | -363.30M | -626.60M | -559.02M | -523.90M |
| Shares Outstanding (Basic) | 82.81M | 79.53M | 76.85M | 74.84M | 71.73M | 70.47M |
| Shares Outstanding (Diluted) | 82.81M | 88.31M | 76.85M | 74.84M | 71.73M | 70.47M |
| EPS (Basic) | -1.28 | 8.58 | -4.73 | -8.37 | -7.79 | -7.43 |
| EPS (Diluted) | -1.28 | 7.78 | -4.73 | -8.37 | -7.79 | -7.43 |
| Free Cash Flow | 2.07M | 702.34M | -114.19M | -186.86M | -388.67M | -279.55M |
| Free Cash Flow Per Share | 0.03 | 7.95 | -1.49 | -2.50 | -5.42 | -3.97 |
| Gross Margin | 55.18% | 70.98% | 26.64% | 21.94% | 0.38% | -6.39% |
| Operating Margin | 21.51% | 49.49% | -18.19% | -37.26% | -62.95% | -69.62% |
| Profit Margin | -9.17% | 39.44% | -45.03% | -66.81% | -80.00% | -97.27% |
| Free Cash Flow Margin | 0.18% | 40.58% | -14.15% | -19.92% | -55.62% | -51.90% |
| EBITDA | 309.56M | 895.32M | -71.08M | -112.81M | -311.09M | -310.81M |
| EBITDA Margin | 26.79% | 51.73% | -8.81% | -12.03% | -44.52% | -57.71% |
| D&A For EBITDA | 61.01M | 38.81M | 75.66M | 236.59M | 128.84M | 64.13M |
| EBIT | 248.55M | 856.51M | -146.75M | -349.40M | -439.93M | -374.94M |
| EBIT Margin | 21.51% | 49.49% | -18.19% | -37.26% | -62.95% | -69.62% |
| Effective Tax Rate | 2.01% | |||||
| Revenue as Reported | 1.16B | 1.73B | 806.78M | 937.82M | 698.80M | 538.59M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 508.89M | 984.65M | 779.71M | 594.00M | 279.83M | 189.72M |
| Short-Term Investments | 1.62B | 960.72M | 373.75M | 288.81M | 130.87M | 583.66M |
| Cash & Short-Term Investments | 2.13B | 1.95B | 1.15B | 882.81M | 410.70M | 773.38M |
| Receivables | 238.07M | 181.62M | 158.55M | 261.02M | 155.61M | 110.45M |
| Inventory | 109.33M | 79.65M | 23.19M | 30.58M | 21.81M | 15.86M |
| Prepaid Expenses | 62.47M | 58.51M | 22.93M | 41.62M | 105.66M | 54.68M |
| Other Current Assets | 8.80M | 7.40M | 2.60M | |||
| Total Current Assets | 2.54B | 2.27B | 1.37B | 1.22B | 693.78M | 954.37M |
| Property, Plant & Equipment | 122.28M | 135.42M | 117.66M | 178.99M | 175.02M | 130.01M |
| Long-Term Investments | 21.00M | |||||
| Goodwill | 82.34M | 82.34M | 82.34M | 82.34M | 82.34M | 82.34M |
| Other Intangible Assets | 443.69M | 388.75M | 118.79M | 379.50M | 705.89M | 724.84M |
| Other Long-Term Assets | 21.63M | 18.30M | 20.70M | 36.25M | 48.58M | 25.50M |
| Total Assets | 3.21B | 2.90B | 1.71B | 1.90B | 1.71B | 1.94B |
| Accounts Payable | 41.59M | 45.49M | 17.27M | 6.04M | 27.27M | 23.03M |
| Accrued Expenses | 381.54M | 314.63M | 261.72M | 366.26M | 276.33M | 251.82M |
| Current Portion of Long-Term Debt | 319.08M | 569.63M | 257.82M | 194.31M | 72.15M | 208.83M |
| Current Portion of Leases | 14.21M | 15.48M | 13.36M | 16.00M | 12.37M | 10.27M |
| Current Income Taxes Payable | 4.68M | 4.70M | 4.71M | 1.29M | ||
| Current Unearned Revenue | 1.98M | 2.04M | 5.50M | 801.00K | 1.35M | |
| Other Current Liabilities | 17.68M | 16.47M | 20.60M | 19.67M | 12.05M | 14.10M |
| Total Current Liabilities | 776.08M | 968.43M | 580.98M | 603.10M | 406.24M | 509.35M |
| Long-Term Debt | 2.52B | 2.03B | 2.11B | 1.90B | 1.26B | 956.59M |
| Long-Term Leases | 85.55M | 96.58M | 90.52M | 114.81M | 119.53M | 93.67M |
| Long-Term Deferred Tax Liabilities | 55.91M | 102.83M | 137.11M | |||
| Other Long-Term Liabilities | 14.50M | 13.70M | 22.23M | 36.44M | 166.64M | 239.90M |
| Total Liabilities | 3.40B | 3.10B | 2.80B | 2.71B | 2.05B | 1.94B |
| Common Stock | 82.00K | 80.00K | 77.00K | 75.00K | 72.00K | 71.00K |
| Additional Paid-In Capital | 2.74B | 2.75B | 2.57B | 2.47B | 2.31B | 2.12B |
| Retained Earnings | -2.94B | -2.96B | -3.65B | -3.28B | -2.66B | -2.10B |
| Comprehensive Income & Other | 2.55M | 10.50M | -25.89M | -1.28M | 4.80M | -24.28M |
| Shareholders' Equity | -191.21M | -205.31M | -1.10B | -818.55M | -347.09M | 1.44M |
| Total Liabilities & Equity | 3.21B | 2.90B | 1.71B | 1.90B | 1.71B | 1.94B |
| Total Debt | 2.94B | 2.71B | 2.47B | 2.23B | 1.46B | 1.27B |
| Net Cash (Debt) | -813.72M | -761.69M | -1.32B | -1.35B | -1.05B | -495.99M |
| Net Cash Per Share | -9.83 | -8.63 | -17.15 | -17.99 | -14.65 | -7.04 |
| Filing Date Shares Outstanding | 83.54M | 82.77M | 78.87M | 76.61M | 73.82M | 71.36M |
| Total Common Shares Outstanding | 83.54M | 81.47M | 77.70M | 75.71M | 73.10M | 70.83M |
| Working Capital | 1.76B | 1.31B | 784.55M | 615.53M | 287.55M | 445.02M |
| Book Value Per Share | -2.29 | -2.52 | -14.13 | -10.81 | -4.75 | 0.02 |
| Tangible Book Value | -717.24M | -676.41M | -1.30B | -1.28B | -1.14B | -805.74M |
| Tangible Book Value Per Share | -8.59 | -8.30 | -16.72 | -16.91 | -15.53 | -11.38 |
| Machinery | 64.40M | 59.76M | 84.19M | 66.64M | 50.80M | |
| Construction In Progress | 2.80M | 3.03M | 24.01M | 14.35M | 9.02M | |
| Leasehold Improvements | 35.16M | 31.53M | 30.17M | 28.97M | 19.94M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -105.97M | 682.64M | -363.30M | -626.60M | -559.02M | -523.90M |
| Depreciation & Amortization | 61.01M | 38.81M | 75.66M | 236.59M | 128.84M | 64.13M |
| Other Amortization | 1.77M | 1.22M | 1.20M | 1.87M | 1.90M | 1.85M |
| Loss (Gain) From Sale of Assets | 30.00K | 130.00K | 4.30M | |||
| Asset Writedown & Restructuring Costs | 597.00K | 1.02M | 163.64M | 217.80M | 33.38M | |
| Loss (Gain) From Sale of Investments | -15.39M | -20.64M | -20.23M | -4.12M | 19.00M | 17.98M |
| Stock-Based Compensation | 89.06M | 74.55M | 74.61M | 131.21M | 110.33M | 103.51M |
| Other Operating Activities | 2.80M | -13.98M | -144.32M | -111.16M | 3.84M | 108.88M |
| Change in Accounts Receivable | -37.86M | -10.15M | 1.73M | -1.54M | -48.47M | -44.99M |
| Change in Inventory | -58.11M | -53.90M | 6.16M | -8.18M | -6.67M | 1.80M |
| Change in Accounts Payable | 87.56M | 71.74M | -33.32M | 48.35M | 27.54M | 45.66M |
| Change in Unearned Revenue | 307.00K | -4.00M | 4.92M | -550.00K | 1.35M | -4.01M |
| Change in Other Net Operating Assets | -15.31M | -56.26M | 121.25M | -42.08M | -68.69M | -22.25M |
| Operating Cash Flow | 10.49M | 711.20M | -107.69M | -158.42M | -356.65M | -251.33M |
| Capital Expenditures | -8.42M | -8.86M | -6.50M | -28.44M | -32.02M | -28.21M |
| Sale of Property, Plant & Equipment | 70.00K | 28.06M | ||||
| Sale (Purchase) of Intangibles | -43.39M | -291.15M | -67.75M | -92.18M | -120.44M | -57.12M |
| Investment in Securities | -572.88M | -562.04M | -59.62M | -56.12M | 442.64M | 304.51M |
| Other Investing Activities | 150.00M | |||||
| Investing Cash Flow | -624.70M | -861.98M | 44.18M | -176.74M | 290.18M | 219.18M |
| Long-Term Debt Issued | 300.00M | |||||
| Long-Term Debt Repaid | -1.61M | -1.49M | -301.38M | -151.28M | -2.22M | |
| Net Debt Issued (Repaid) | 131.47M | -1.61M | -1.49M | -301.38M | 148.72M | -2.22M |
| Issuance of Common Stock | 90.65M | 99.05M | 33.76M | 29.99M | 71.08M | 23.10M |
| Other Financing Activities | 225.43M | 233.66M | 223.59M | 917.78M | -51.85M | |
| Financing Cash Flow | 447.55M | 331.09M | 255.87M | 646.40M | 167.95M | 20.88M |
| Foreign Exchange Rate Adjustments | 5.70M | 22.71M | -7.33M | 3.11M | -2.77M | -7.82M |
| Net Cash Flow | -160.97M | 203.02M | 185.03M | 314.36M | 98.71M | -19.09M |
| Free Cash Flow | 2.07M | 702.34M | -114.19M | -186.86M | -388.67M | -279.55M |
| Free Cash Flow Margin | 0.18% | 40.58% | -14.15% | -19.92% | -55.62% | -51.90% |
| Free Cash Flow Per Share | 0.03 | 7.95 | -1.49 | -2.50 | -5.42 | -3.97 |
| Levered Free Cash Flow | 159.94M | 211.76M | -80.23M | -31.73M | -313.75M | -214.16M |
| Unlevered Free Cash Flow | 282.18M | 305.68M | 25.07M | 47.13M | -258.86M | -162.25M |
| Cash Interest Paid | 3.43M | 5.70M | 5.82M | 36.13M | 18.46M | 9.59M |
| Cash Income Tax Paid | 5.70M | 36.85M | 17.55M | 14.15M | 4.92M | 7.71M |
| Change in Working Capital | -23.41M | -52.56M | 100.74M | -4.00M | -94.94M | -23.79M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 5.01B | 6.10B | 3.48B | 2.08B | 2.79B | 2.82B |
| Enterprise Value | 5.82B | 6.88B | 4.94B | 3.25B | 3.67B | 3.21B |
| Last Close Price | 59.97 | 75.96 | 45.14 | 27.56 | 38.17 | 39.83 |
| PE Ratio | 8.93 | |||||
| PS Ratio | 4.34 | 3.52 | 4.32 | 2.22 | 3.99 | 5.23 |
| PB Ratio | -29.70 | -3.17 | -2.54 | -8.03 | 1,958.20 | |
| P/FCF Ratio | 2,423.88 | 8.68 | ||||
| P/OCF Ratio | 477.75 | 8.57 | ||||
| EV/Sales Ratio | 5.04 | 3.98 | 6.12 | 3.47 | 5.25 | 5.95 |
| EV/EBITDA Ratio | 18.81 | 7.69 | ||||
| EV/EBIT Ratio | 23.43 | 8.04 | ||||
| EV/FCF Ratio | 2,817.55 | 9.80 | ||||
| Debt / Equity Ratio | -15.38 | -13.19 | -2.25 | -2.72 | -4.21 | 882.73 |
| Debt / EBITDA Ratio | 8.89 | 2.95 | ||||
| Debt / FCF Ratio | 1,423.14 | 3.85 | ||||
| Net Debt / Equity Ratio | -4.26 | -3.71 | -1.20 | -1.65 | -3.03 | 344.92 |
| Net Debt / EBITDA Ratio | 2.63 | 0.85 | -18.54 | -11.93 | -3.38 | -1.60 |
| Net Debt / FCF Ratio | 393.67 | 1.08 | -11.54 | -7.21 | -2.70 | -1.77 |
| Asset Turnover | 0.40 | 0.75 | 0.45 | 0.52 | 0.38 | 0.26 |
| Inventory Turnover | 6.39 | 9.77 | 22.02 | 27.95 | 36.97 | 33.17 |
| Quick Ratio | 3.05 | 2.20 | 2.26 | 1.90 | 1.39 | 1.74 |
| Current Ratio | 3.27 | 2.35 | 2.35 | 2.02 | 1.71 | 1.87 |
| Return on Equity (ROE) | -216.75% | |||||
| Return on Assets (ROA) | 5.31% | 23.26% | -5.09% | -12.13% | -15.09% | -11.30% |
| Return on Invested Capital (ROIC) | 10.12% | 54.96% | -12.14% | -26.96% | -48.97% | -76.84% |
| Return on Capital Employed (ROCE) | 10.20% | 44.40% | -13.10% | -27.00% | -33.90% | -26.20% |
| Earnings Yield | -2.13% | 11.19% | -10.44% | -30.13% | -20.06% | -18.61% |
| FCF Yield | 0.04% | 11.52% | -3.28% | -8.98% | -13.95% | -9.93% |
| Buyback Yield / Dilution | 1.98% | -14.92% | -2.68% | -4.33% | -1.79% | -6.72% |